Electroacupuncture extends the time window of thrombolytic therapy in rats by reducing disruptions of blood–brain barrier and inhibiting GSDMD-mediated pyroptosis
Brain Research · 2024-12 · 1845 · 149296
DOI: 10.1016/j.brainres.2024.149296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2024-12. Verfasst von Huanhuan Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Acupuncture-Moxibustion and Tuina, Nanjing University of Chinese Medicine, Nanjing 210023, China; Key Laboratory of Acupuncture and Medici…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Electroacupuncture, Pyroptosis, Rats, Sprague-Dawley. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE: Thrombolytic therapy is the primary treatment for acute ischemic stroke. Extending the therapeutic time window can effectively reduce the harmful side effects associated with thrombolytic therapy. Although electroacupuncture (EA) has been shown to extend this time window, the specific mechanisms remain unclear. METHODS: We developed an embolic stroke model in rats and administered EA during thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) either 4.5 or 6 h after stroke onset. Neurological deficits were evaluated at 2 and 24 h post-stroke. Brain tissue was collected for analysis using 2,3,5-triphenyl tetrazolium chloride (TTC) staining, water content measurement, blood-brain barrier (BBB) permeability assessment, electron microscopy, and TUNEL assay. Immunofluorescence staining, western blotting, and enzyme-linked immunosorbent assays were employed to quantify the expression of proteins related to BBB integrity and pyroptosis. RESULTS: Neuronal damage and BBB disruption along with increased expression of pyroptosis-related proteins were observed following thrombolytic therapy at the 6-hour mark. EA treatment improved neurological outcomes, reduced infarct volume, and alleviated BBB disruption. EA also inhibited the expression of matrix metalloproteinase 9 (MMP9) and enhanced the expression of tissue inhibitor of metalloproteinases 1 (TIMP1), helping to maintain BBB integrity. Furthermore, EA reduced the expression of pyroptosis-related proteins, including gasdermin D (GSDMD), interleukin-1β (IL-1β), and interleukin-18 (IL-18). EA also reduced the co-expression of GSDMD and MMP9 in brain tissues. CONCLUSIONS: EA may be a promising therapeutic approach for extending the thrombolytic therapy window by protecting the BBB and inhibiting GSDMD-mediated pyroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Acupuncture-Moxibustion and Tuina, Nanjing University of Chinese Medicine, Nanjing 210023, China; Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Me…
- School of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, H., Shen, Y., Huang, Z., Jiang, T., Huang, P., Yang, M., Zhang, X., Xu, W., & Ni, G. (2024). Electroacupuncture extends the time window of thrombolytic therapy in rats by reducing disruptions of blood–brain barrier and inhibiting GSDMD-mediated pyroptosis. Brain Research, 1845, 149296. https://doi.org/10.1016/j.brainres.2024.149296
Vancouver
Liu H, Shen Y, Huang Z, Jiang T, Huang P, Yang M, et al. Electroacupuncture extends the time window of thrombolytic therapy in rats by reducing disruptions of blood–brain barrier and inhibiting GSDMD-mediated pyroptosis. Brain Research. 2024;1845:149296. doi:10.1016/j.brainres.2024.149296
BibTeX
@article{Liu2024,
author = {Liu, Huanhuan and Shen, Yiting and Huang, Zheng and Jiang, Tao and Huang, Peiyan and Yang, Mengning and Zhang, Xinchang and Xu, Wentao and Ni, Guangxia},
title = {Electroacupuncture extends the time window of thrombolytic therapy in rats by reducing disruptions of blood–brain barrier and inhibiting GSDMD-mediated pyroptosis},
journal = {Brain Research},
year = {2024},
volume = {1845},
pages = {149296},
doi = {10.1016/j.brainres.2024.149296}
}
EUVIMED